Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

FPPQ

From Wikipedia, the free encyclopedia

FPPQ
Identifiers
  • 1-(3-fluorophenyl)sulfonyl-4-piperazin-1-ylpyrrolo[3,2-c]quinoline
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC21H19FN4O2S
Molar mass410.47 g·mol−1
3D model (JSmol)
  • C1CN(CCN1)C2=NC3=CC=CC=C3C4=C2C=CN4S(=O)(=O)C5=CC=CC(=C5)F
  • InChI=1S/C21H19FN4O2S/c22-15-4-3-5-16(14-15)29(27,28)26-11-8-18-20(26)17-6-1-2-7-19(17)24-21(18)25-12-9-23-10-13-25/h1-8,11,14,23H,9-10,12-13H2
  • Key:QNKGTIWNFNPEJL-UHFFFAOYSA-N

FPPQ is an experimental drug related to quipazine, which acts as a selective antagonist of both the 5-HT3 and 5-HT6 serotonin receptors. It has antipsychotic and memory-enhancing effects in animal studies.[1][2]

References

[edit]
  1. Zajdel P, Grychowska K, Mogilski S, Kurczab R, Satała G, Bugno R, et al. (September 2021). "Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties". Journal of Medicinal Chemistry. 64 (18): 13279–13298. doi:10.1021/acs.jmedchem.1c00224. PMC 8474115. PMID 34467765.
  2. Castañé A, Cano M, Ruiz-Avila L, Miquel-Rio L, Celada P, Artigas F, et al. (May 2022). "Dual 5-HT3 and 5-HT6 Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats". The International Journal of Neuropsychopharmacology. 25 (5): 425–431. doi:10.1093/ijnp/pyac003. PMC 9154270. PMID 35022720.